Two Sigma Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $5.06M | Buy |
|
|||||
2024
Q4 | $5.19M | Buy |
|
|||||
2024
Q3 | $3.21M | Sell |
|
|||||
2024
Q2 | $4.42M | Sell |
|
|||||
2024
Q1 | $6.56M | Sell |
|
|||||
2023
Q4 | $6.08M | Sell |
|
|||||
2023
Q3 | $5.06M | Sell |
|
|||||
2023
Q2 | $6.01M | Sell |
|
|||||
2023
Q1 | $8.03M | Sell |
|
|||||
2022
Q4 | $20.7M | Sell |
|
|||||
2022
Q3 | $48.5M | Buy |
|
|||||
2022
Q2 | $52.1M | Buy |
|
|||||
2022
Q1 | $50.9M | Buy |
|
|||||
2021
Q4 | $11.1M | Buy |
|
|||||
2021
Q3 | $9.45M | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $2.1M | Sell |
|
|||||
2020
Q3 | $11.7M | Sell |
|
|||||
2020
Q2 | $13.1M | Buy |
|
|||||
2020
Q1 | $5.54M | Buy |
|
|||||
2019
Q4 | $290K | Sell |
|
|||||
2019
Q3 | $1.23M | Sell |
|
|||||
2019
Q2 | $2.2M | Sell |
|
|||||
2019
Q1 | $4.68M | Sell |
|
|||||
2018
Q4 | $4.38M | Sell |
|
|||||
2018
Q3 | $7.29M | Sell |
|
|||||
2018
Q2 | $8.71M | Sell |
|
|||||
2018
Q1 | $8.83M | Buy |
|
|||||
2017
Q4 | $8.53M | Sell |
|
|||||
2017
Q3 | $13.6M | Sell |
|
|||||
2017
Q2 | $26.3M | Buy |
|
|||||
2017
Q1 | $21.1M | Buy |
|
|||||
2016
Q4 | $14M | Buy |
|
|||||
2016
Q3 | $2.81M | Buy |
|
|||||
2016
Q2 | – | Sell |
|
|||||
2016
Q1 | $4.49M | Buy |
|
|||||
2015
Q4 | $3.72M | Sell |
|
|||||
2015
Q3 | $3.56M | Buy |
|
|||||
2015
Q2 | $3.75M | Sell |
|
|||||
2015
Q1 | $11.2M | Buy |
|
|||||
2014
Q4 | $5.06M | Sell |
|
|||||
2014
Q3 | $12.1M | Sell |
|
|||||
2014
Q2 | $13.3M | Sell |
|
|||||
2014
Q1 | $18.6M | Buy |
|
|||||
2013
Q4 | $2.73M | Buy |
|
|||||
2013
Q3 | $2.29M | Buy |
|
|||||
2013
Q2 | $2.01M | Buy |
|